Tim Vanmierlo holds a position as an associate professor between Maastricht University (0.5fte) and Hasselt University (0.5fte) and on the research line "repair-inducing cognition enhancers". In this context, his team applies a battery of gene-editing approaches (e.g. CRISPR/Cas9, in vivo micro-electroporation) to modulate biological processes to enable CNS repair in MS and AD. The established cross-border initiative between UHasselt BIOMED with the school for mental health and neuroscience (MHeNs) at Maastricht University merges knowledge and expertise on cognition enhancers applying gene-editing approaches.